http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102123716-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e0d9727734afed01f86f4f34df64a8f4
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7084
filingDate 2009-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d190ba3e5b94fcb8fa1297401253bc61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c59541d8e917524180891085f4e09f1
publicationDate 2011-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102123716-A
titleOfInvention Compositions and methods for treating viral infections
abstract The present invention provides methods and compositions for treatment of a virus infection, especially a HCV infection and a coinfection of a HCV and other virus such as HBV and/or HIV. In one embodiment, the present invention provides a compound having a formula (I) or pharmaceutically acceptable salts, ester, stereoisomers, tautomer, solvate, prodrug or mix thereof, and use thereof in the treatment of the virus infection.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105992587-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111484540-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111484540-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113164506-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110467646-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107922455-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020151295-A1
priorityDate 2008-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466904857
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466699457
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466948732
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467873598

Total number of triples: 38.